Kingland Partners

We are only able to display limited information for this firm. We display more complete information for all of the following firms:

Rapidly growing Kingland Partners provides a wide scope of life science expertise, including M&A, product transactions, research and development, as well as licensing, capital markets and compliance to clients in the pharmaceutical, biotechnology and medical device industries. Practice heads Huawei Lin, Zhibin Li and Daniel Mao excel in fund formation, venture capital and M&A matters. Jing Lu is equipped to handle CSO deals, data compliance and complex licensing in and out transactions.
Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • ‘Jing Lu's team serves most multinational pharmaceutical companies in the life sciences industry. They are well aware of the innovative projects our entire industry is undertaking, as well as common problems and solutions. While protecting their clients' business secrets, they extract commonalities and provide us with practical suggestions. 

  • ‘Jing Lu is highly responsive and hands-on, providing high-quality service to clients. He understands the common pain points of clients across the industry and their actual needs, providing feedback that clients can directly implement.'

Key clients

  • AIC
  • Johnson & Johnson